U.S. FDA Clears MYCO-001 for Multi-Site Government Funded
DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology...
Source: globenewswire.com
Stay updated with breaking news from Industry Sponsored Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology...
17.06.2022 - DENVER, June 17, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology aiming to transform the treatment of mental health and addiction disorders, today announced ... Seite 1